Abstract Background Angiotensin receptor blockers (ARBs) are commonly used as a
treatment for many cardiovascular diseases, but their safety has been called into question …

Aims The uncertainty surrounding safety of angiotensin receptor blockers (ARBs) increased
after publication of experimental and clinical studies which suggested an excess risk of …

855 cause MI, 24 we were both intrigued and puzzled; intrigued because, like ACE
inhibitors, ARBs were expected to reduce MI, yet puzzled because they had only reported …

Methods. In order to explore the potential influence of ARBs on MI, we performed a more
comprehensive meta-analysis, including all major international, randomized trials (18 trials …

Objective To evaluate the effects of treatments based on angiotensin II receptor blockers
(ARBs) on the risk of myocardial infarction (MI), cardiovascular and all-cause death, as …

ABSTRACT Introduction Angiotensin receptor blockers (ARBs) are recommended as
preferential drugs in the treatment of hypertension by guidelines. In this review, we …

Introduction: Angiotensin II receptor blockers (ARBs) are antihypertensive agents with
considerable evidence of efficacy and safety for the reduction of cardiovascular (CV) …

Objectives To evaluate the cardiovascular outcomes and other outcomes associated with
angiotensin receptor blockers. Design Systematic review of randomised controlled trials with …

Cardiovascular and renal disease can be regarded as progressing along a sort of
continuum which starts with cardiovascular risk factors (hypertension, diabetes …

Angiotensin receptor blockers (ARBs) are the most commonly used among blood pressure-
lowering drugs worldwide, despite the absence of sound evidence of effectiveness in large …